• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Lifeway Foods Inc. (Amendment)

    5/19/23 4:44:28 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email
    SC 13D/A 1 lifeway_13da16.htm SCHEDULE 13D AMENDMENT 16

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 16)*

     

    LIFEWAY FOODS, INC.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    531914109

    (CUSIP Number)

     

    Edward Smolyansky
    1219 N Wells St

    Chicago, IL 60610

    (847) 967-1010

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    May 19, 2023

    (Date of Event Which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

       

     

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    Ludmila Smolyansky

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)     [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      1,952,130
     
    8. Shared voting power      0
     
    9. Sole dispositive power      1,952,130
     
    10. Shared dispositive power       0
     
      11.

    Aggregate amount beneficially owned by each reporting person

    1,952,130

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (see instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    13.3%

     
      14.

    Type of reporting person (see instructions)

    IN

               

     

     

     2 

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    Edward Smolyansky

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)     [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      2,182,772
     
    8. Shared voting power      500,000
     
    9. Sole dispositive power      2,182,772
     
    10. Shared dispositive power      500,000
     
      11.

    Aggregate amount beneficially owned by each reporting person

    2,682,772

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (see instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    18.3%

     
      14.

    Type of reporting person (see instructions)

    IN

               

     

     

     3 

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    The Edward Smolyansky Trust 2/2/16

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)   [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      833,333
     
    8. Shared voting power      0
     
    9. Sole dispositive power      833,333
     
    10. Shared dispositive power      0
     
      11.

    Aggregate amount beneficially owned by each reporting person

    833,333

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (see instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    5.7%

     
      14.

    Type of reporting person (see instructions)

    OO

               

     

     4 

     

     

    AMENDMENT NO. 16 to SCHEDULE 13D

     

    This Amendment No. 16 further amends and supplements the Schedule 13D filed by Ludmila Smolyansky and Edward Smolyansky (together with The Edward Smolyansky Trust 2/2/16, the “Filing Persons”). This Amendment No. 16 is being filed by the Filing Persons for the purpose of providing the additional information set forth below.

     

    ITEM 2. Identity and Background

     

    Item 2 is hereby amended and supplemented by the addition of the following:

     

    On May 16, 2023, Ludmila Smolyansky resigned her position as a director of Lifeway Foods, Inc. (the “Company”). Her principal business address is c/o Edward Smolyansky, 1219 N Wells St, Chicago, IL 60610. Her present principal occupation is businessperson, and she is not presently employed.

     

    Item 4. Purpose of Transaction

     

    Item 4 is hereby amended and supplemented by the addition of the following:

     

    On March 16, 2023 and March 17, 2023, Mr. Smolyansky notified the Company, in accordance with the Company’s bylaws, that he intended to nominate seven candidates for election as directors at the Company’s 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”) and that he intended to solicit proxies in accordance with the relevant conditions of Rule 14a-19 under the Securities Exchange Act of 1934 (the “Exchange Act”).

     

    On April 14, 2023, the Company filed a lawsuit against Ludmila Smolyansky and Mr. Smolyansky in the Circuit Court of Cook County, Illinois. The Company alleged, among other claims, that Ludmila Smolyansky and Mr. Smolyansky breached the Settlement Agreement, dated as of July 27, 2022, as amended, among the Company, Ludmila Smolyansky and Edward Smolyansky (the “Settlement Agreement”) and certain other contractual obligations. In addition, the Company disclosed in its complaint that, as of the date of its filing, the Company had still not engaged a financial advisor.

     

    On April 30, 2023, the Company filed a definitive proxy statement with the Securities and Exchange Commission (the “SEC”) with respect to the 2023 Annual Meeting, which disclosed that the 2023 Annual Meeting had been scheduled for June 15, 2023.

     

    On May 5, 2023, Mr. Smolyansky again notified the Company, in accordance with the Company’s bylaws, that he intended to nominate seven candidates for election as directors at the 2023 Annual Meeting, and that he intended to solicit proxies in accordance with the relevant conditions of Rule 14a-19 under the Exchange Act.

     

    On May 19, 2023, Mr. Smolyansky filed a definitive proxy statement with the SEC, pursuant to which he intends to solicit proxies for the election of the seven director nominees named in his notices to the Company.

     

     

     

     5 

     

     

    ITEM 5. Interest in Securities of the Issuer

     

    Item 5 is hereby amended and supplemented by the addition of the following:

     

    (a)As of May 19, 2023, Ludmila Smolyansky may be deemed for purposes of Rule 13d-3 under the Exchange Act, to be the beneficial owner of 1,952,130 shares of Common Stock, representing approximately 13.3% of the outstanding shares of Common Stock, Edward Smolyansky may be deemed to be the beneficial owner of 2,682,772 shares of Common Stock, representing approximately 18.3% of the outstanding shares of Common Stock, the Trust may be deemed to be the beneficial owner of 833,333 shares of Common Stock, representing approximately 5.7% of the outstanding shares of Common Stock, and the Filing Persons together may be deemed to be the beneficial owners of an aggregate of 4,847,902 shares of Common Stock, representing approximately 31.6% of outstanding shares of Common Stock. The foregoing percentage calculations were based on 14,656,155 shares outstanding as of May 10, 2023, as reported by the Company on its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, as filed with the SEC.
       
    (b)Ludmila Smolyansky has sole power to vote or to direct the vote of, and sole power to dispose or direct the disposition of, 1,952,130 shares of Common Stock. Edward Smolyansky has sole power to vote or direct the vote of, and sole power to dispose or direct the disposition of, 2,182,772 shares of Common Stock, which includes the 833,333 shares beneficially owned by the Trust, and shared power to vote or direct the vote of, and shared power to dispose or direct the disposition of, 500,000 shares of Common Stock, which are held by Smolyansky Family Holdings LLC. Edward Smolyansky disclaims beneficial ownership of shares held by Smolyansky Family Holdings LLC, except to the extent of any pecuniary interest therein. The Trust has sole power to vote or direct the vote of, and sole power to dispose or direct the disposition of, 833,333 shares of Common Stock.
       
    (c)Except as set forth below, there have been no transactions in the shares of Common Stock by any of the Filing Persons during the past sixty days:

     

    Date Reporting Person Amount Acquired (Disposed) Price Per Share Type of Transaction
    March 28, 2023 Edward Smolyansky (5,000) $5.95 Open market sale
    March 28, 2023 Edward Smolyansky (13,000) $5.90 Open market sale
    March 28, 2023 Edward Smolyansky (7,300) $6.00 Open market sale
    March 28, 2023 Edward Smolyansky (1,100) $5.96 Open market sale
    March 28, 2023 Edward Smolyansky (1,600) $5.91 Open market sale
    March 30, 2023 Edward Smolyansky (10,000 $6.00 Open market sale
    March 30, 2023 Edward Smolyansky (786) $6.05 Open market sale
    March 30, 2023 Edward Smolyansky (200) $6.02 Open market sale
    March 30, 2023 Edward Smolyansky (14) $6.02 Open market sale
    March 30, 2023 Edward Smolyansky (4,000) $6.01 Open market sale
    March 30, 2023 Ludmila Smolyansky (125,000) $6.00 Open market sale
    March 31, 2023 Edward Smolyansky (30,000) $6.00 Open market sale
    May 16, 2023 Edward Smolyansky (10,000) $6.00 Open market sale
    May 17, 2023 Edward Smolyansky (5,000) $6.03 Open market sale

     

     

     

     6 

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

     

    Date: May 19, 2023 /s/ Ludmila Smolyansky                      
    Ludmila Smolyansky

     

    Date: May 19, 2023 /s/ Edward Smolyansky                       
    Edward Smolyansky

     

      THE EDWARD SMOLYANSKY TRUST 2/2/16
       
    Date:May 19, 2023 By: /s/ Edward Smolyansky                 
    Name: Edward Smolyansky
      Title: Trustee

     

     

     

     

     

     7 

     

    Get the next $LWAY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    9/25/2023Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    SEC Filings

    View All

    Lifeway Foods Inc. filed SEC Form 8-K: Leadership Update

    8-K - Lifeway Foods, Inc. (0000814586) (Filer)

    11/7/25 4:30:31 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Lifeway Foods, Inc. (0000814586) (Filer)

    11/4/25 4:30:30 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Lifeway Foods, Inc. (0000814586) (Filer)

    10/29/25 7:57:26 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edward Smolyansky Issues Statement Regarding Lifeway Foods (NASDAQ: LWAY) Extension of Existing Rights Plan, Board Refreshment and Delayed 2025 Annual Meeting

    Extension protects entrenched board and management rather than maximizesshareholder value; shareholders must demand an immediate vote. CHICAGO, Nov. 7, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, long-term shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY) who together exercise voting control with respect to approximately 26% of the outstanding shares of Lifeway Foods today provided a response to the Company's extension of its existing Shareholder Rights Agreement (the "Rights Plan") as well as an update on the upcoming Lifeway Foods 2025 election. On October 29, 2025, the Board of Lifeway Foods approved an amendment to its Shareholder Rights Agreement, extending its expiration date

    11/7/25 10:15:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® to Report Third Quarter 2025 Results on November 12, 2025

    MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect

    11/5/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Awarded on TIME's America's Growth Leaders 2026 Ranking

    Leading kefir company ranks 33rd overall and 2nd among Food & Beverage companies MORTON GROVE, Ill., Nov. 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, is proud to announce its inclusion in the America's Growth Leaders 2026 list, a distinguished ranking honoring companies demonstrating exceptional growth performance, financial stability, and stock performance. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com.

    11/3/25 12:30:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Drori Rachel

    3 - Lifeway Foods, Inc. (0000814586) (Issuer)

    11/7/25 4:30:06 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Member of 10% owner group Smolyansky Ludmila sold $396,000 worth of shares (15,000 units at $26.40) (SEC Form 4)

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    10/9/25 8:28:27 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Large owner Smolyansky Edward sold $2,166,926 worth of shares (83,643 units at $25.91), decreasing direct ownership by 7% to 1,151,642 units (SEC Form 4)

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    10/3/25 4:34:30 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

    9/24/24 8:32:49 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods upgraded by Noble Capital Markets with a new price target

    Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

    5/30/24 9:15:56 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lake Street initiated coverage on Lifeway Foods with a new price target

    Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00

    4/5/24 8:42:53 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Kefir Brand Lifeway Foods' CEO Julie Smolyansky Launches Industry Conversation to Explore New Voluntary Dairy Certification Standard

    Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and

    6/17/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    View All

    Lifeway Foods® to Report Third Quarter 2025 Results on November 12, 2025

    MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect

    11/5/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Delivers Record Q2 2025 Net Sales, Extends Kefir Category Leadership, and Estimates Over 20% Q3 Net Sales Growth to Date

    Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly six years of uninterrupted net sales growth Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of $26.4 million in net sales for the third quarter-to-date through August 11, up over 20% year-over-year MORTON GROVE, Ill., Aug. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for th

    8/12/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® Announces Record Week Surpassing $5.5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

    Company Plans to Report Second Quarter 2025 Results on August 12, 2025 MORTON GROVE, Ill., July 15, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5.5 million in gross sales for the week ending July 13th, 2025, representing a 66% increase from the prior year. The Company expects to report financial results for the second quarter ended June 30, 2025 on August 12, 2025 before market hours. A pre

    7/15/25 9:15:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 4:33:49 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 8:53:57 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    9/23/24 4:07:26 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples